Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1041

1.
2.

Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.

Glasper A, Gossop M, de Wet C, Reed L, Bearn J.

Pharmacology. 2008;81(2):92-6. Epub 2007 Oct 19.

PMID:
17952010
3.

Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.

Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, Wiese B, Emrich HM, Schneider U.

Pharmacopsychiatry. 2002 Sep;35(5):159-64.

PMID:
12237786
5.

Induction of patients with moderately severe methadone dependence onto buprenorphine.

Glasper A, Reed LJ, de Wet CJ, Gossop M, Bearn J.

Addict Biol. 2005 Jun;10(2):149-55.

PMID:
16191667
6.

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.

Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL.

Drug Alcohol Depend. 2003 Apr 1;69(3):263-72.

PMID:
12633912
7.

Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.

Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.

Arch Gen Psychiatry. 2005 Oct;62(10):1157-64.

PMID:
16203961
8.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002025. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD002025.

PMID:
15495026
9.

Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study.

Tamaskar R, Parran TV Jr, Heggi A, Brateanu A, Rabb M, Yu J.

J Addict Dis. 2003;22(4):5-12.

PMID:
14723474
10.

Opioid dependence: rationale for and efficacy of existing and new treatments.

Fiellin DA, Friedland GH, Gourevitch MN.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S173-7. Review.

PMID:
17109303
11.

Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.

Kakko J, Heilig M, Sarman I.

Drug Alcohol Depend. 2008 Jul 1;96(1-2):69-78. doi: 10.1016/j.drugalcdep.2008.01.025. Epub 2008 Mar 19.

PMID:
18355989
12.

Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine.

White R, Alcorn R, Feinmann C.

Drug Alcohol Depend. 2001 Dec 1;65(1):77-83.

PMID:
11714592
13.

[Detoxification of poly-substance abusers with buprenorphine. Effects on affect, anxiety, and withdrawal symptoms].

Paetzold W, Eronat V, Seifert J, Holze I, Emrich HM, Schneider U.

Nervenarzt. 2000 Sep;71(9):722-9. German.

PMID:
11042867
14.

In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.

McCambridge J, Gossop M, Beswick T, Best D, Bearn J, Rees S, Strang J.

Drug Alcohol Depend. 2007 Apr 17;88(1):91-5. Epub 2006 Oct 24.

PMID:
17064857
15.

Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.

Lubman D, Koutsogiannis Z, Kronborg I.

Drug Alcohol Rev. 2003 Dec;22(4):433-6.

PMID:
14660133
16.

A meta-analysis comparing the effectiveness of buprenorphine and methadone.

West SL, O'Neal KK, Graham CW.

J Subst Abuse. 2000;12(4):405-14.

PMID:
11452842
17.

Clinical efficacy of buprenorphine: comparisons to methadone and placebo.

Ling W, Wesson DR.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S49-57. Review.

PMID:
12738350
18.

Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome.

de Wet C, Reed L, Glasper A, Moran P, Bearn J, Gossop M.

Drug Alcohol Depend. 2004 Oct 5;76(1):31-5.

PMID:
15380286
19.

Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives.

Wallen MC, Lorman WJ, Gosciniak JL.

J Addict Dis. 2006;25(1):23-31.

PMID:
16597570
20.

Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.

Seifert J, Metzner C, Paetzold W, Borsutzky M, Ohlmeier M, Passie T, Hauser U, Becker H, Wiese B, Emrich H, Schneider U.

Addict Biol. 2005 Jun;10(2):157-64.

PMID:
16191668

Supplemental Content

Support Center